8.2 Physical and Chemical Incompatibilities: pH Effects, Salt Formations & Precipitation Mechanisms

8.2 Physical and Chemical Incompatibilities: pH Effects, Salt Formations & Precipitation Mechanisms

---

Diagnostic Taxonomy: Physical vs. Chemical Incompatibility

Sterile admixture incompatibilities fall into two fundamentally distinct scientific categories:

1. Physical Incompatibilities: A macroscopic, visible, or colligative phase change occurring upon the combination of two or more substances. Physical incompatibilities alter the state of matter (e.g., solid-liquid phase changes, gas evolution, or immiscibility) but do not initially involve the cleavage or synthesis of covalent molecular bonds. Physical events include crystalline precipitation, co-solvent dilution collapse, phase separation (lipid emulsion cracking), and sorption onto container surfaces.
2. Chemical Incompatibilities: An irreversible chemical reaction that alters the covalent architecture of the drug molecule, creating distinct degradation products. Chemical incompatibilities are often completely invisible to visual inspection—a crystal-clear, colorless solution may suffer a $50\%$ loss in potency within hours due to active-site cleavage. The primary chemical mechanisms are hydrolysis, oxidation-reduction, photolysis, and covalent polymerization.

---

Physical Incompatibilities: Mechanisms of Precipitation & Phase Collapse

1. pH-Dependent Ionization & Acid-Base Precipitation

Most parenteral drugs are formulated as water-soluble salts of weak organic acids or weak organic bases. In aqueous solution, weak electrolytes exist in dynamic equilibrium between their ionized (polar, charged, hydrophilic, water-soluble) form and their unionized (non-polar, uncharged, lipophilic, poorly water-soluble) free form.

This thermodynamic balance is described by the Henderson-Hasselbalch equations:

$\text{For Weak Acids: } \text{pH} = \text{p}K_a + \log\left(\frac{[\text{A}^-]}{[\text{HA}]}\right) \iff \frac{[\text{A}^-]}{[\text{HA}]} = 10^{(\text{pH} - \text{p}K_a)}$

$\text{For Weak Bases: } \text{pH} = \text{p}K_a + \log\left(\frac{[\text{B}]}{[\text{BH}^+]}\right) \iff \frac{[\text{B}]}{[\text{BH}^+]} = 10^{(\text{pH} - \text{p}K_a)}$

Where:

• $[\text{A}^-]$ is the water-soluble ionized conjugate base; $[\text{HA}]$ is the insoluble unionized free acid.
• $[\text{BH}^+]$ is the water-soluble ionized conjugate acid; $[\text{B}]$ is the insoluble unionized free base.

      WEAK ACID DRUGS (Phenytoin, Furosemide)              WEAK BASE DRUGS (Midazolam, Morphine)
 ┌─────────────────────────────────────────────┐    ┌─────────────────────────────────────────────┐
 │ High pH (> 8-12) ──► Fully Ionized [A-]     │    │ Low pH (< 3-5) ──► Fully Ionized [BH+]      │
 │ (Water Soluble - Stable Commercial Vial)    │    │ (Water Soluble - Stable Commercial Vial)    │
 ├─────────────────────────────────────────────┤    ├─────────────────────────────────────────────┤
 │ Acidic Diluent (D5W / NS) ──► pH Drops      │    │ Alkaline Diluent (NaHCO3) ──► pH Rises      │
 │ Precipitates as INSOLUBLE FREE ACID [HA]!   │    │ Precipitates as INSOLUBLE FREE BASE [B]!    │
 └─────────────────────────────────────────────┘    └─────────────────────────────────────────────┘

Weak Acid Precipitation in Acidic Environments

• Phenytoin Sodium: Phenytoin is an extremely weak acid ($\text{p}K_a \approx 8.3$). Commercial phenytoin injection is formulated at a caustic $\text{pH}$ of $12.0$ using $40\%$ propylene glycol and $10\%$ ethanol to force the drug into its ionized conjugate base ($[\text{A}^-]$). When phenytoin is introduced into an acidic IV fluid like $5\%\,\text{Dextrose}$ ($\text{pH} \approx 4.0-4.5$), the local $\text{pH}$ drops precipitously below its $\text{p}K_a$. Protons force the equilibrium backward toward unionized free phenytoin ($[\text{HA}]$), which has an aqueous solubility of only a few tens of micrograms per milliliter. Needle-like macroscopic crystals instantly shower out of solution.
• Furosemide: Formulated as a sodium salt at $\text{pH } 8.5\text{ to }9.3$. Combining furosemide with acidic infusions (e.g., milrinone, midazolam, or dopamine) neutralizes the carboxylate ion, causing instantaneous precipitation of insoluble free furosemide.

Weak Base Precipitation in Alkaline Environments

• Midazolam Hydrochloride, Ondansetron HCl, Morphine Sulfate: These basic drugs are formulated as salts of strong acids (hydrochlorides or sulfates) at acidic $\text{pH } (3.0\text{ to }4.0)$ to ensure complete protonation into $[\text{BH}^+]$. If mixed with alkaline solutions—such as $8.4\%\,\text{Sodium Bicarbonate}$ ($\text{pH} \approx 8.0$), ampicillin sodium ($\text{pH} \approx 9.0$), or cefepime—the excess hydroxyl ions strip protons from the amine moiety, converting the drug into its uncharged free base ($[\text{B}]$), which rapidly precipitates as a milky cloud.

2. Co-Solvent Dilution Collapse (Water Dilution Shock)

Lipophilic drugs that cannot be solubilized through salt formation alone are commercially formulated with non-aqueous co-solvents (such as propylene glycol, ethanol, polyethylene glycol 400, or benzyl alcohol). These organic co-solvents disrupt the hydrogen-bonding matrix of water, decreasing the dielectric constant of the solvent and boosting drug solubility by thousands of times.

• Representative Co-Solvent Formulations: Diazepam ($40\%$ propylene glycol, $10\%$ ethanol), Lorazepam ($80\%$ propylene glycol, $18\%$ polyethylene glycol 400), Digoxin ($40\%$ propylene glycol, $10\%$ ethanol), Paclitaxel (Cremophor EL and $50\%$ ethanol).
• The Collapse Mechanism: When a co-solvent vial is injected rapidly into an aqueous large-volume parenteral bag (such as normal saline or dextrose), the co-solvent is instantly diluted throughout the bulk water. As the local organic solvent concentration falls below the critical solubilization concentration, the thermodynamic activity of the lipophilic drug spikes, causing the solute to crash out of solution as microscopic or visible flakes.

3. Gas Evolution (Effervescence)

Certain sterile admixtures produce gas through acid-base chemical reactions. A classic example is Ceftazidime for injection. Commercial ceftazidime vials are dry-blended with sodium carbonate excipient. When reconstituted with sterile diluent, an acid-base neutralization occurs between the acidic ceftazidime and the carbonate ion, releasing significant volumes of carbon dioxide ($\text{CO}_2$) gas. Compounding personnel must use venting needles or specialized pressure-relief transfer systems to equilibrate internal vial pressure, preventing aerosolized spray or stoppers violently dislodging.

---

Chemical Incompatibilities: Covalent Degradation Pathways

 ┌────────────────────────────────────────────────────────────────────────────────────────┐
 │                         PRIMARY CHEMICAL DEGRADATION PATHWAYS                          │
 ├────────────────────────────┬─────────────────────────────┬─────────────────────────────┤
 │         HYDROLYSIS         │          OXIDATION          │        PHOTODEGRADATION     │
 ├────────────────────────────┼─────────────────────────────┼─────────────────────────────┤
 │ • Nucleophilic water attack│ • Free-radical auto-ox      │ • Photon-induced cleavage   │
 │ • Cleaves beta-lactam rings│ • Attacks phenols, catechols│ • Cleaves nitroprusside Fe-CN│
 │ • Hydrolyzes ester/amides  │ • Catalyzed by Fe3+, Cu2+   │ • Generates toxic CYANIDE   │
 │ • Accelerated by heat & pH │ • Forms colored quinones    │ • Requires immediate foil / │
 │ • Stabilized by cold / dry │ • Shield via bisulfite/EDTA │   amber light shielding     │
 └────────────────────────────┴─────────────────────────────┴─────────────────────────────┘

1. Hydrolysis

Hydrolysis is the nucleophilic cleavage of a covalent chemical bond by water molecules or hydroxyl ions ($\text{OH}^-$):

• Beta-Lactam Ring Hydrolysis: Penicillins, cephalosporins, and carbapenems contain a strained, four-membered beta-lactam ring. Nucleophilic attack by water opens the ring, generating therapeutically inactive and potentially allergenic penicilloic acid derivatives. Ampicillin is exceptionally unstable in aqueous solution, exhibiting rapid, concentration-dependent self-catalyzed dimerization and ring-opening hydrolysis within hours.
• Ester and Amide Cleavage: Ester linkages (such as in remifentanil, esmolol, procaine, and methylprednisolone sodium succinate) are cleaved into corresponding carboxylic acids and alcohols.
• Thermodynamic Dependencies: Hydrolysis reaction rates follow the Arrhenius relationship and the $Q_{10}$ rule: the degradation rate typically doubles or triples for every $10^\circ\text{C}$ rise in temperature. Hydrolysis is also strongly pH-dependent, exhibiting a characteristic V-shaped or U-shaped pH-rate profile with a specific pH of maximum stability (typically $\text{pH } 4.0\text{ to }7.0$).

2. Auto-Oxidation

Oxidation is the removal of electrons from a molecule, often initiated by molecular oxygen ($\text{O}_2$) and mediated via free-radical chain mechanisms (initiation, propagation, termination). Trace multivalent transition metal impurities (such as $\text{Fe}^{3+}$ and $\text{Cu}^{2+}$) catalyze single-electron transfers that generate reactive hydroxyl and superoxide radicals.

• Susceptible Functional Groups: Catecholamines (epinephrine, norepinephrine, dopamine, isoproterenol), phenolic compounds (morphine, acetaminophen), and sulfhydryl-containing moieties (cysteine).
• Visual Manifestation: Oxidation of catecholamines yields colored ortho-quinones, which polymerize into pink, amber, or brown adrenochrome pigments. Any discolored catecholamine infusion must be immediately condemned and discarded.
• Formulation Protection Strategies:
  • Sacrificial Antioxidants: Sodium metabisulfite, sodium bisulfite, sodium sulfite (act as preferred electron donors, scavenging radicals).
  • Metal Chelating Agents: Disodium edetate (EDTA), which complexes trace catalytic transition metal ions into unreactive coordination spheres.
  • Headspace Sparging: Bubbling high-purity inert gas (nitrogen or argon) through the liquid and displacing ambient air from the vial headspace during packaging.

3. Photodegradation (Photolysis)

Photolysis occurs when a drug molecule absorbs ultraviolet or visible electromagnetic photons, promoting ground-state electrons to excited singlet or triplet states that undergo homolytic bond cleavage or free-radical generation.

• Other Photosensitive Therapeutics: Dacarbazine (turns pink upon photolysis), Amphotericin B deoxycholate, Phytonadione (vitamin $\text{K}_1$), Doxycycline, and Furosemide.

---

Container-Solution Interactions: Sorption & DEHP Leaching Phenomena

Parenteral containers and administration tubing are manufactured from specialized polymers. When compounded drugs contact polymeric surfaces, two distinct physical phenomena can compromise clinical safety and dosing accuracy:

      SORPTION (Loss of Drug from Solution)                 LEACHING (Extraction of Toxic Plasticizer)
 ┌──────────────────────────────────────────────┐     ┌──────────────────────────────────────────────┐
 │ ADSORPTION: Surface adhesion of drug         │     │ PVC matrix contains 30-40% unbound DEHP      │
 │ molecules onto plastic / glass walls.        │     │ plasticizer to impart flexibility.           │
 │                                              │     │                                              │
 │ ABSORPTION: Lipophilic drug dissolves into   │     │ Surfactants (Cremophor EL, Polysorbate 80)   │
 │ and penetrates the polymeric bulk matrix.    │     │ & Lipids dissolve and LEACH DEHP INTO CSP!   │
 ├──────────────────────────────────────────────┤     ├──────────────────────────────────────────────┤
 │ HIGH-RISK DRUGS:                             │     │ TOXICITIES:                                  │
 │ • Nitroglycerin (up to 80% lost in PVC!)     │     │ • Hepatotoxicity, chemical peritonitis       │
 │ • Diazepam, Amiodarone, Lorazepam            │     │ • Endocrine disruption & reproductive defect │
 │ • Regular Insulin (surface adsorption)       │     │ • Neonatal / pediatric male testicular harm  │
 └──────────────────────────────────────────────┘     └──────────────────────────────────────────────┘

1. Sorption Phenomena: Adsorption vs. Absorption

• Adsorption (Surface Effect): Drug molecules bind electrostatically or via Van der Waals forces directly onto the internal fluid-contact surface of the container or IV tubing.
  • Regular Human Insulin: Readily adsorbs onto both borosilicate glass and plastic polymers. When initiating continuous regular insulin infusions, the tubing line must be primed and permitted to stand briefly to saturate available surface adsorption binding sites, ensuring steady-state delivery.
• Absorption (Matrix Penetration): Lipophilic, unionized drug molecules physically dissolve into the polymer matrix of standard polyvinyl chloride (PVC) containers and tubing, diffusing away from the fluid pathway.
  • Nitroglycerin: Up to $80\%$ of a nitroglycerin dose is rapidly absorbed into standard plasticized PVC infusion tubing. Administering nitroglycerin via standard PVC sets results in profound underdosing and acute hypertensive crises. Nitroglycerin must be compounded exclusively in non-PVC containers (polyolefin, glass) and infused through dedicated non-PVC, non-absorbing administration sets.
  • Other High-Sorption Drugs: Amiodarone, Diazepam, Lorazepam, Tacrolimus, Carmustine.

2. DEHP Plasticizer Leaching Mechanics

Standard PVC is an inherently rigid, brittle polymer. To manufacture flexible IV bags and pliable tubing sets, manufacturers incorporate up to $30\%$ to $40\%$ by weight of a chemical plasticizer: di(2-ethylhexyl) phthalate (DEHP). Crucially, DEHP is not chemically crosslinked or covalently bound to the PVC polymer chains; it is merely suspended within the interstitial polymeric spaces.

• Extraction Catalysts: Lipophilic formulation components, surfactant solubilizers, and intravenous fat emulsions act as organic extraction solvents that pull lipophilic DEHP out of the PVC matrix directly into the drug solution.
  • Polyoxyethylated Castor Oil (Cremophor EL): Formulating surfactant for Paclitaxel and Teniposide; extracts massive quantities of DEHP.
  • Polysorbate 80 (Tween 80): Surfactant present in Docetaxel and Amiodarone.
  • Intravenous Fat Emulsions (IVFE / TNAs): Lipid triglycerides readily dissolve and extract DEHP.
• Clinical Toxicology of DEHP: DEHP is an endocrine disruptor, hepatotoxin, and peroxisome proliferator. It induces developmental male reproductive tract toxicity (atrophy of seminiferous tubules and suppressed testosterone production). Neonates, pediatric intensive care patients, and patients undergoing chronic transfusions or lifelong parenteral nutrition face profound risks from DEHP bioaccumulation.

3. Non-PVC Polymeric Alternatives

To prevent both sorption loss and DEHP leaching, modern sterile compounding utilizes advanced inert contact materials:

• Polyolefin (Polypropylene / Polyethylene Copolymers): Thermoplastic material containing zero plasticizers, zero DEHP, and minimal drug sorption. Standard for nitroglycerin, amiodarone, and paclitaxel infusions.
• Ethylene Vinyl Acetate (EVA): Highly flexible, DEHP-free polymer used universally for compounding total parenteral nutrition (TPN) and total nutrient admixture (TNA) bags.
• Polyethylene-Lined Administration Sets: Feature a co-extruded structure consisting of a flexible PVC outer jacket for kink-resistance and durability, bonded to an inert inner liner of pure polyethylene that forms the actual fluid-contact lumen.
• Type I Borosilicate Glass: Chemically inert and impermeable, but requires vented IV administration sets to allow air displacement.

---

In-Line Filtration Standards & Pore Sizing Architecture

In-line intravenous filters are critical physical barriers that capture particulate matter, microbial bioburden, endotoxin-bearing cell fragments, and accidental precipitates before they reach the patient's vascular bed.

---

High-Risk Incompatibility Reference Matrix